NCT04676945View on ClinicalTrials.gov

Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients

CompletedOBSERVATIONAL
Enrollment

9,179

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

August 20, 2021

Study Completion Date

November 21, 2022

Conditions
Myelodysplastic Syndromes
Trial Locations (1)

1140

Hanusch Krankenhaus, 3.Medizinische Abteilung, Vienna

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Michael Pfeilstöcker

OTHER